INSIGHTS

Richard King Mellon Foundation Commits Up to $25 Million to Launch Rare Ventures ™, a First-of-its-Kind Platform for Accelerating Rare Disease Therapies

Join our Newsletter

Get insights delivered to your inbox.

Download Resource

Enter your email to get access to the resource

View Full Resource

Access directly from its original publisher.

Visit Resource
Share

more Resources

News

Oct 2025

Peptilogics secures $78M to advance treatment for prosthetic joint infections

News

Feb 2026

AIxBio Driving Discovery and Manufacturing Boom in Pittsburgh

News

Aug 2025

PLSA President and CEO Megan Shaw joined BioBuzz